Imagine living with a relentless, excruciating pain that feels like your insides are being twisted and knotted in every direction. This is the reality for women battling endometriosis, a condition that has left many feeling frozen in agony. But what if a simple injection could offer a year of relief? That’s exactly what pelvic Botox promised—until it was abruptly pulled from the ACT public health system, leaving patients in limbo. And this is the part most people miss: while it’s not a cure-all, for some, it’s been nothing short of life-changing.
Take Amy Lane, a Canberra mother-of-two who has endured endometriosis for decades. Despite a hysterectomy, countless surgeries, and constant medication, her pain remains unpredictable. On her worst days, she’s reduced to crawling across the floor, unable to move without agony. ‘It’s like hot knives in your lower back,’ she describes. ‘It just freezes you.’ But in August last year, she found hope in pelvic Botox injections. These needles, administered into the pelvis, relax overactive muscles—similar to how Botox treats migraines or muscle spasms. For Amy, it was revolutionary. She began swimming, walking, and living without the constant fear of triggering unbearable pain. ‘It gave me my life back,’ she says.
But here’s where it gets controversial: despite success stories like Amy’s, the ACT government halted the procedure, citing ‘unknown risks’ and limited scientific evidence. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) recommends pelvic physio as the first line of treatment, calling Botox a last resort. Yet, for many, physio hasn’t been accessible—Amy has been on the public waitlist since October 2024 with no progress. Now, patients like her are forced to choose between traveling interstate or paying thousands privately for Botox injections.
Advocates like Jess McGowan, who experienced a significant drop in pain after the procedure, argue this is a matter of equity. ‘Only those who can afford it get this healthcare,’ Amy points out. ‘Why should I have to travel to Sydney for something that works?’ Jess, who hasn’t worked full-time in 15 years due to her condition, is now considering selling her possessions to afford the treatment. ‘I can’t go back to how it was before,’ she says.
The debate rages on: Is pelvic Botox a risky experiment, or a lifeline for those who’ve exhausted all other options? RANZCOG’s Dr. Marilla Druitt emphasizes the importance of evidence-based treatments like physio, but acknowledges the system’s failures. ‘It breaks my heart,’ she says, ‘that patients are left with no safe, accessible alternatives.’
A petition to reinstate the procedure has gained momentum, and QENDO has appealed to ACT Health Minister Rachel Stephen-Smith, highlighting emerging evidence of Botox’s effectiveness. The ACT government remains open to research proposals but insists on caution. Meanwhile, patients like Amy and Jess are left wondering: What’s the alternative?
Thought-provoking question for you: Should healthcare systems prioritize caution over patient-reported relief, especially when safer options are inaccessible? Share your thoughts in the comments—let’s spark a conversation that could change lives.
